Diffusion Basis Spectrum Imaging of the Prostate
Part of paid clinical trials in St Louis, Missouri.
- Sponsor
- Washington University School of Medicine
- Study ID
- NCT04420702
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MRI with DBSI analysis — DEVICE-The procedure will take approximately 1 hour of the participant's time
Study Details
Diffusion Basis Spectrum Imaging (DBSI) represents a potential leap forward in improving prostate cancer early detection: a non-invasive and accurate imaging test for clinically significant prostate cancer.
Key Dates
- Start date
- Feb 27, 2020
- Status verified
- Jul 2025
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 500 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Early Detection Cohort (MRI with DBSI)* Magnetic resonance imaging (MRI) with DBSI analysis prior to prostate biopsy * Standard of care prostate biopsy will be performed within 12 weeks of MRI * Some participants may go on to receive standard of care radical prostatectomy and those participants may have their prostatectomy specimens scanned via MRI with DBSI imaging
- Experimental: Active Surveillance Cohort (MRI with DBSI)* Magnetic resonance imaging (MRI) with DBSI analysis prior to prostate biopsy * Standard of care prostate biopsy will be performed within 12 weeks of MRI * Some participants may go on to receive standard of care radical prostatectomy and those participants may have their prostatectomy specimens scanned via MRI with DBSI imaging
Primary Outcome Measure
Area under the curve (AUC) comparison from biopsy and DBSI [ Time Frame: Up to 12 weeks ]
Central Contacts
- Joseph Ippolito, M.D.314-362-2925
- Alex Klim314-747-9781
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Washington University School of Medicine | St Louis | Missouri | 63110 | Joseph Ippolito, M.D. (PRINCIPAL_INVESTIGATOR) Sheng-Kwei Song, Ph.D. (SUB_INVESTIGATOR) Michael H Johnson, M.D. (SUB_INVESTIGATOR) |
Find similar trials in St Louis, MO
By condition
By specialty
By research site
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPHASE2 · Recruiting · Astellas Pharma Global Development, Inc. · Anchorage, Alaska
- Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate BrachytherapyPHASE1/PHASE2 · Recruiting · Washington University School of Medicine · St Louis, Missouri
- Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical ProstatectomyPHASE2 · Recruiting · David Oh · San Francisco, California